These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Single photon emission computerized tomography with capromab pendetide plus computerized tomography image set co-registration independently predicts biochemical failure. Ellis RJ; Zhou EH; Fu P; Kaminsky DA; Sodee DB; Faulhaber PF; Bodner D; Resnick MI J Urol; 2008 May; 179(5):1768-73; discussion 1773-4. PubMed ID: 18343445 [TBL] [Abstract][Full Text] [Related]
30. 99mTc-CD19 monoclonal antibody is not useful for imaging of B cell non-Hodgkin's lymphoma. Vervoordeldonk SF; Heikens J; Goedemans WT; Merle PA; von dem Borne AE; van Royen EA; Slaper-Cortenbach IC; van Oers RH Cancer Immunol Immunother; 1996 Jun; 42(5):291-6. PubMed ID: 8706051 [TBL] [Abstract][Full Text] [Related]
31. Comparison of helical computerized tomography, positron emission tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancer. Seltzer MA; Barbaric Z; Belldegrun A; Naitoh J; Dorey F; Phelps ME; Gambhir SS; Hoh CK J Urol; 1999 Oct; 162(4):1322-8. PubMed ID: 10492189 [TBL] [Abstract][Full Text] [Related]
33. Indium-111-capromab pendetide radioimmunoscintigraphy and prognosis for durable biochemical response to salvage radiation therapy in men after failed prostatectomy. Thomas CT; Bradshaw PT; Pollock BH; Montie JE; Taylor JM; Thames HD; McLaughlin PW; DeBiose DA; Hussey DH; Wahl RL J Clin Oncol; 2003 May; 21(9):1715-21. PubMed ID: 12721246 [TBL] [Abstract][Full Text] [Related]
34. FDG-PET detection of primary bone marrow large B-cell lymphoma in a patient with hairy cell leukemia. Paolini R; Bianchini E; D'Andrea E; Al-Nahhas A; Banti E; Muzzio PC; Rubello D Nucl Med Rev Cent East Eur; 2007; 10(1):23-5. PubMed ID: 17694498 [TBL] [Abstract][Full Text] [Related]
35. Capromab Pendetide immunoscintigraphy: connecting the dots for prostate cancer imaging. Manyak MJ Cancer Biother Radiopharm; 2000 Apr; 15(2):127-30. PubMed ID: 10803317 [No Abstract] [Full Text] [Related]
36. Capromab pendetide. A review of its use as an imaging agent in prostate cancer. Lamb HM; Faulds D Drugs Aging; 1998 Apr; 12(4):293-304. PubMed ID: 9571393 [TBL] [Abstract][Full Text] [Related]
37. Initial clinical results with technetium-99m-labeled LL2 monoclonal antibody fragment in the radioimmunodetection of B-cell lymphomas. Baum RP; Niesen A; Hertel A; Adams S; Kojouharoff G; Goldenberg DM; Hör G Cancer; 1994 Feb; 73(3 Suppl):896-9. PubMed ID: 8306276 [TBL] [Abstract][Full Text] [Related]
38. Development of a 124I-labeled version of the anti-PSMA monoclonal antibody capromab for immunoPET staging of prostate cancer: Aspects of labeling chemistry and biodistribution. Tolmachev V; Malmberg J; Estrada S; Eriksson O; Orlova A Int J Oncol; 2014 Jun; 44(6):1998-2008. PubMed ID: 24718894 [TBL] [Abstract][Full Text] [Related]
39. Role of ProstaScint for brachytherapy in localized prostate adenocarcinoma. Ellis RJ; Kim E; Foor R Expert Rev Mol Diagn; 2004 Jul; 4(4):435-41. PubMed ID: 15225091 [TBL] [Abstract][Full Text] [Related]
40. Use of 111in-capromab pendetide immunoscintigraphy to image localized prostate cancer foci within the prostate gland. Mouraviev V; Madden JF; Broadwater G; Mayes JM; Burchette JL; Schneider F; Smith J; Tsivian M; Wong T; Polascik TJ J Urol; 2009 Sep; 182(3):938-47. PubMed ID: 19616259 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]